Jinneng Science&Technology Co.,Ltd (SHA:603113)
China · Delayed Price · Currency is CNY 5.82
-0.23 (-3.80%)
May 7, 2026, 3:00 PM CST
SHA:603113 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 15,540 | 16,678 | 15,403 | 13,945 | 15,488 | 10,493 |
Other Revenue | 234.88 | 234.88 | 858.05 | 638.66 | 1,312 | 1,520 |
| 15,775 | 16,913 | 16,261 | 14,584 | 16,801 | 12,013 | |
Revenue Growth (YoY) | -9.00% | 4.01% | 11.50% | -13.20% | 39.85% | 59.22% |
Cost of Revenue | 16,294 | 16,699 | 15,983 | 14,126 | 16,157 | 10,412 |
Gross Profit | -518.3 | 213.96 | 278.42 | 458.09 | 643.94 | 1,601 |
Selling, General & Admin | 194 | 194.76 | 214.16 | 213.55 | 236.16 | 282.1 |
Research & Development | 142.44 | 153.53 | 134.26 | 113.85 | 144.11 | 162.02 |
Other Operating Expenses | -18.92 | -31.99 | -84.55 | -1.61 | 59.88 | 58.49 |
Operating Expenses | 324.75 | 323.53 | 235.3 | 342.2 | 459.62 | 517.19 |
Operating Income | -843.05 | -109.57 | 43.12 | 115.89 | 184.32 | 1,084 |
Interest Expense | -93.58 | -93.58 | -169.66 | -165.75 | -117.26 | -42.09 |
Interest & Investment Income | 271.81 | 272.7 | 59.4 | 109.24 | 65.85 | 57.19 |
Currency Exchange Gain (Loss) | -55.16 | -55.16 | -64.61 | -70.59 | -39.31 | 4.88 |
Other Non Operating Income (Expenses) | -48.34 | -50.28 | -29.22 | -10.61 | -39.71 | 2.14 |
EBT Excluding Unusual Items | -768.31 | -35.88 | -160.97 | -21.82 | 53.89 | 1,106 |
Gain (Loss) on Sale of Investments | -55.75 | 2.77 | -8.03 | - | - | - |
Gain (Loss) on Sale of Assets | 17.37 | 19 | -5.61 | 0.4 | 106.57 | 5.22 |
Asset Writedown | 3.63 | -3.11 | -0.06 | 0.17 | -26.93 | -59.35 |
Legal Settlements | -2.58 | -2.58 | -2.14 | - | - | - |
Other Unusual Items | 46.4 | 46.4 | 86.78 | 107.93 | 112.13 | 77.78 |
Pretax Income | -759.24 | 26.61 | -90.01 | 86.68 | 245.66 | 1,130 |
Income Tax Expense | -114.8 | 4.57 | -32.14 | -50.7 | -3.51 | 203.76 |
Net Income | -644.45 | 22.04 | -57.87 | 137.38 | 249.17 | 925.81 |
Net Income to Common | -644.45 | 22.04 | -57.87 | 137.38 | 249.17 | 925.81 |
Net Income Growth | - | - | - | -44.87% | -73.09% | 4.12% |
Shares Outstanding (Basic) | 848 | 848 | 827 | 859 | 859 | 834 |
Shares Outstanding (Diluted) | 848 | 848 | 827 | 859 | 859 | 917 |
Shares Change (YoY) | -1.61% | 2.53% | -3.71% | -0.07% | -6.26% | 10.30% |
EPS (Basic) | -0.76 | 0.03 | -0.07 | 0.16 | 0.29 | 1.11 |
EPS (Diluted) | -0.76 | 0.03 | -0.07 | 0.16 | 0.29 | 1.01 |
EPS Growth | - | - | - | -44.83% | -71.29% | -5.61% |
Free Cash Flow | -1,344 | -190.66 | -270.25 | -1,063 | -2,263 | -614.54 |
Free Cash Flow Per Share | -1.59 | -0.23 | -0.33 | -1.24 | -2.63 | -0.67 |
Dividend Per Share | 0.283 | 0.283 | 0.120 | 0.094 | 0.120 | 0.350 |
Dividend Growth | 135.83% | 135.83% | 27.66% | -21.67% | -65.71% | 0.57% |
Gross Margin | -3.28% | 1.26% | 1.71% | 3.14% | 3.83% | 13.33% |
Operating Margin | -5.34% | -0.65% | 0.27% | 0.80% | 1.10% | 9.02% |
Profit Margin | -4.08% | 0.13% | -0.36% | 0.94% | 1.48% | 7.71% |
Free Cash Flow Margin | -8.52% | -1.13% | -1.66% | -7.29% | -13.47% | -5.12% |
EBITDA | -16.49 | 730.27 | 936.05 | 855.01 | 936.44 | 1,603 |
EBITDA Margin | -0.10% | 4.32% | 5.76% | 5.86% | 5.57% | 13.34% |
D&A For EBITDA | 826.56 | 839.84 | 892.93 | 739.12 | 752.12 | 518.81 |
EBIT | -843.05 | -109.57 | 43.12 | 115.89 | 184.32 | 1,084 |
EBIT Margin | -5.34% | -0.65% | 0.27% | 0.80% | 1.10% | 9.02% |
Effective Tax Rate | - | 17.17% | - | - | - | 18.04% |
Revenue as Reported | 16,913 | 16,913 | 16,261 | 14,584 | 16,801 | 12,013 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.